Effect of Curcumin on Protein Damage Induced by Rotenone in Dopaminergic PC12 Cells
Open Access
- 16 April 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (8), 2761
- https://doi.org/10.3390/ijms21082761
Abstract
Oxidative stress is considered to be a key factor of the pathogenesis of Parkinson’s disease, a multifactorial neurodegenerative disorder characterized by reduced dopaminergic neurons in the substantia nigra pars compacta and accumulated protein aggregates. Rotenone is a worldwide-used pesticide that induces the most common features of Parkinson’s by direct inhibition of the mitochondrial complex I. Rotenone-induced Parkinson’s models, as well as brain tissues from Parkinson’s patients, are characterized by the presence of both lipid peroxidation and protein oxidation markers resulting from the increased level of free radical species. Oxidation introduces several modifications in protein structure, including carbonylation and nitrotyrosine formation, which severely compromise cell function. Due to the link existing between oxidative stress and Parkinson’s disease, antioxidant molecules could represent possible therapeutic tools for this disease. In this study, we evaluated the effect of curcumin, a natural compound known for its antioxidant properties, in dopaminergic PC12 cells treated with rotenone, a cell model of Parkinsonism. Our results demonstrate that the treatment of PC12 cells with rotenone causes severe protein damage, with formation of both carbonylated and nitrotyrosine-derived proteins, whereas curcumin (10 µM) co-exposure exerts protective effects by reducing the levels of oxidized proteins. Curcumin also promotes proteasome activation, abolishing the inhibitory effect exerted by rotenone on this degradative system.This publication has 63 references indexed in Scilit:
- Protein Tyrosine Nitration: Biochemical Mechanisms and Structural Basis of Functional EffectsAccounts of Chemical Research, 2012
- Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for ParkinsonismPharmacological Research, 2011
- Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell modelBMC Neuroscience, 2010
- Transcription Factor Nrf1 Mediates the Proteasome Recovery Pathway after Proteasome Inhibition in Mammalian CellsMolecular Cell, 2010
- Bioconjugates of curcumin display improved protection against glutathione depletion mediated oxidative stress in a dopaminergic neuronal cell line: Implications for Parkinson’s diseaseBioorganic & Medicinal Chemistry, 2010
- Protein CarbonylationAntioxidants and Redox Signaling, 2010
- Nitric Oxide in Health and Disease of the Nervous SystemAntioxidants and Redox Signaling, 2009
- Oxidative Modification of Proteasome: Identification of an Oxidation-Sensitive Subunit in 26 S ProteasomeBiochemistry, 2005
- Geldanamycin induces Hsp70 and prevents α-synuclein aggregation and toxicity in vitroBiochemical and Biophysical Research Communications, 2004
- Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's diseaseAnnals of Neurology, 2004